{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:48:34Z","timestamp":1761515314116,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.4158\/ep.11.5.308","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:38:11Z","timestamp":1365197891000},"page":"308-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of Sibutramine on Blood Pressure in Patients with Obesity and Well-Controlled Hypertension or Normotension"],"prefix":"10.1016","volume":"11","author":[{"given":"Alptekin","family":"G\u00fcrsoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat Faik","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine \u00d6zduman","family":"Cin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Cesur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilg\u00fcn","family":"Ba\u015fkal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1998","series-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report","key":"10.4158\/EP.11.5.308_bb0005"},{"key":"10.4158\/EP.11.5.308_bb0010","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4065\/74.12.1255","article-title":"Safe and effective management of the obese patient","volume":"74","author":"Collazo-Clavell","year":"1999","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP.11.5.308_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1385\/ENDO:13:2:193","article-title":"Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity","volume":"13","author":"Ryan","year":"2000","journal-title":"Endocrine."},{"key":"10.4158\/EP.11.5.308_bb0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199809103391103","article-title":"An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenflu-ramine, or placebo","volume":"339","author":"Weissman","year":"1998","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.11.5.308_bb0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199809103391102","article-title":"A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation","volume":"339","author":"Jick","year":"1998","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.11.5.308_bb0030","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJM199809103391101","article-title":"The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs","volume":"339","author":"Khan","year":"1998","journal-title":"N Engl J Med."},{"issue":"2143","key":"10.4158\/EP.11.5.308_bb0035","first-page":"61","article-title":"Drug therapy for obesity","volume":"2131-2138","author":"Dickerson","year":"2000","journal-title":"Am Fam Physician."},{"key":"10.4158\/EP.11.5.308_bb0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"Sibutramine: a review of its contribution to the management of obesity","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs."},{"key":"10.4158\/EP.11.5.308_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(02)01423-1","article-title":"The discovery and status of sibutramine as an anti-obesity drug","volume":"440","author":"Luque","year":"2002","journal-title":"Eur J Pharmacol."},{"key":"10.4158\/EP.11.5.308_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1467-789x.2000.00020.x","article-title":"An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action","volume":"1","author":"Nisoli","year":"2000","journal-title":"Obes Rev."},{"key":"10.4158\/EP.11.5.308_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.jhh.1001298","article-title":"Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors","volume":"16","author":"McMahon","year":"2002","journal-title":"J Hum Hypertens."},{"key":"10.4158\/EP.11.5.308_bb0060","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/archinte.160.14.2185","article-title":"Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial","volume":"160","author":"McMahon","year":"2000","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.11.5.308_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1463-1326.2000.00081.x","article-title":"Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus","volume":"2","author":"Fujioka","year":"2000","journal-title":"Diabetes Obes Metab."},{"key":"10.4158\/EP.11.5.308_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","article-title":"Sibutramine produces dose-related weight loss","volume":"7","author":"Bray","year":"1999","journal-title":"Obes Res."},{"key":"10.4158\/EP.11.5.308_bb0075","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","article-title":"The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction","volume":"23","author":"Hansen","year":"1999","journal-title":"Int J Obes Relat Metab Disord."},{"key":"10.4158\/EP.11.5.308_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","article-title":"Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine","volume":"106","author":"Apfelbaum","year":"1999","journal-title":"Am J Med."},{"key":"10.4158\/EP.11.5.308_bb0085","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.ijo.0802574","article-title":"Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study","volume":"28","author":"Ersoz","year":"2004","journal-title":"Int J Obes Relat Metab Disord."},{"key":"10.4158\/EP.11.5.308_bb0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1590\/S0066-782X2002000200006","article-title":"Effects of sibutramine on the treatment of obesity in patients with arterial hypertension [article in English, Portuguese]","volume":"78","author":"Faria","year":"2002","journal-title":"Arq Bras Cardiol."},{"key":"10.4158\/EP.11.5.308_bb0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000047310","article-title":"Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients","volume":"94","author":"Hazenberg","year":"2000","journal-title":"Cardiology."},{"key":"10.4158\/EP.11.5.308_bb0100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1067\/mhj.2002.124403","article-title":"Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction","volume":"144","author":"Zannad","year":"2002","journal-title":"Am Heart J."},{"key":"10.4158\/EP.11.5.308_bb0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.5694\/j.1326-5377.2002.tb04590.x","article-title":"Ambulatory blood pressure monitoring","volume":"176","year":"2002","journal-title":"Med J Aust."},{"key":"10.4158\/EP.11.5.308_bb0110","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/oby.2003.152","article-title":"Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials","volume":"11","author":"Kim","year":"2003","journal-title":"Obes Res."},{"issue":"Suppl","key":"10.4158\/EP.11.5.308_bb0115","first-page":"A110","article-title":"Effect of sibutramine versus placebo on blood pressure in randomized, double-blind controlled trials: a retrospective analysis [abstract]","volume":"11","author":"Sharma","year":"2003","journal-title":"Obes Res."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20401909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20401909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/0BM8T0W3KT4QQ2FN.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:45:12Z","timestamp":1761515112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20401909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1530891X20401909"],"URL":"https:\/\/doi.org\/10.4158\/ep.11.5.308","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Sibutramine on Blood Pressure in Patients with Obesity and Well-Controlled Hypertension or Normotension","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.11.5.308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}